SK284860B6 - Použitie p-aminofenolového derivátu na výrobu liečiva na liečenie neurodegeneratívnych chorôb - Google Patents

Použitie p-aminofenolového derivátu na výrobu liečiva na liečenie neurodegeneratívnych chorôb Download PDF

Info

Publication number
SK284860B6
SK284860B6 SK1598-98A SK159898A SK284860B6 SK 284860 B6 SK284860 B6 SK 284860B6 SK 159898 A SK159898 A SK 159898A SK 284860 B6 SK284860 B6 SK 284860B6
Authority
SK
Slovakia
Prior art keywords
paracetamol
indomethacin
treatment
neurodegenerative diseases
cells
Prior art date
Application number
SK1598-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK159898A3 (en
Inventor
Mario Pinza
Mario Brufani
Claudio Milanese
Original Assignee
Angelini Ricerche S. P. A. Societa Consortile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche S. P. A. Societa Consortile filed Critical Angelini Ricerche S. P. A. Societa Consortile
Publication of SK159898A3 publication Critical patent/SK159898A3/sk
Publication of SK284860B6 publication Critical patent/SK284860B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1598-98A 1996-05-21 1997-05-15 Použitie p-aminofenolového derivátu na výrobu liečiva na liečenie neurodegeneratívnych chorôb SK284860B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI001013A IT1282736B1 (it) 1996-05-21 1996-05-21 Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative
PCT/EP1997/002708 WO1997044020A1 (en) 1996-05-21 1997-05-15 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases

Publications (2)

Publication Number Publication Date
SK159898A3 SK159898A3 (en) 2000-04-10
SK284860B6 true SK284860B6 (sk) 2006-01-05

Family

ID=11374289

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1598-98A SK284860B6 (sk) 1996-05-21 1997-05-15 Použitie p-aminofenolového derivátu na výrobu liečiva na liečenie neurodegeneratívnych chorôb

Country Status (19)

Country Link
US (1) US6043285A (pt)
EP (1) EP0946162B1 (pt)
JP (1) JP2000510859A (pt)
AT (1) ATE252897T1 (pt)
AU (1) AU723004B2 (pt)
CZ (1) CZ295875B6 (pt)
DE (1) DE69725879T2 (pt)
DK (1) DK0946162T3 (pt)
EA (1) EA003251B1 (pt)
ES (1) ES2208909T3 (pt)
HU (1) HU225536B1 (pt)
IL (1) IL127044A (pt)
IT (1) IT1282736B1 (pt)
NZ (1) NZ333232A (pt)
PT (1) PT946162E (pt)
SK (1) SK284860B6 (pt)
TR (1) TR199802384T2 (pt)
WO (1) WO1997044020A1 (pt)
ZA (1) ZA974387B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI962356A1 (it) * 1996-11-13 1998-05-13 Uni Degli Studi Di Brescia D I Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
DE19911626A1 (de) * 1999-03-16 2000-09-28 Strathmann Ag & Co Induktion antiinflammatorisch wirkender Proteine durch Ammoniumionen bzw. Amino-Reste
BR9904931A (pt) * 1999-10-18 2001-06-12 Sergio Teixeira Ferreira Inibição de amiloidoses
US6664297B1 (en) * 2000-10-18 2003-12-16 Universidade Federal Do Rio De Janeiro Methods for inhibition and dissolution of amyloidoses by administration of compositions comprising 2,4-dinitrophenol
AU2003298514A1 (en) * 2002-05-17 2004-05-04 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
GB0310300D0 (en) * 2003-05-06 2003-06-11 Univ Belfast Nanocomposite drug delivery composition
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
JP5466006B2 (ja) * 2006-09-03 2014-04-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
JP2010529101A (ja) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
JP5757864B2 (ja) 2008-05-20 2015-08-05 ニューロジェシックス， インコーポレイテッド 水溶性アセトアミノフェン類似体
EP2291084A4 (en) 2008-05-20 2012-04-25 Neurogesx Inc CARBONATE PRODRUGS AND METHOD FOR THEIR USE
MX362949B (es) 2008-12-04 2019-02-27 Yu Chongxi Composiciones de alta penetracion y sus aplicaciones.
CN107929743B (zh) 2012-01-18 2023-09-01 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
JP5997658B2 (ja) * 2013-05-08 2016-09-28 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN115835862A (zh) * 2020-07-10 2023-03-21 广州新创忆药物临床研究有限公司 治疗阿尔茨海默病的组合及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions
US5643960A (en) * 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
US5756548A (en) * 1995-04-03 1998-05-26 Centaur Pharmaceuticals, Inc. Acetamidobenzamide compounds for neurodegenerative disorders

Also Published As

Publication number Publication date
IL127044A0 (en) 1999-09-22
EA003251B1 (ru) 2003-02-27
JP2000510859A (ja) 2000-08-22
IL127044A (en) 2001-03-19
TR199802384T2 (xx) 1999-03-22
NZ333232A (en) 2000-08-25
CZ295875B6 (cs) 2005-11-16
CZ374998A3 (cs) 1999-04-14
ITMI961013A1 (it) 1997-11-21
DK0946162T3 (da) 2004-03-01
EP0946162A1 (en) 1999-10-06
US6043285A (en) 2000-03-28
SK159898A3 (en) 2000-04-10
HUP9904027A2 (hu) 2000-05-28
AU3092397A (en) 1997-12-09
ZA974387B (en) 1997-12-23
HUP9904027A3 (en) 2000-07-28
ATE252897T1 (de) 2003-11-15
WO1997044020A1 (en) 1997-11-27
IT1282736B1 (it) 1998-03-31
PT946162E (pt) 2004-03-31
DE69725879D1 (de) 2003-12-04
ES2208909T3 (es) 2004-06-16
HU225536B1 (en) 2007-02-28
EP0946162B1 (en) 2003-10-29
DE69725879T2 (de) 2004-09-02
EA199801028A1 (ru) 1999-06-24
ITMI961013A0 (pt) 1996-05-21
AU723004B2 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
SK284860B6 (sk) Použitie p-aminofenolového derivátu na výrobu liečiva na liečenie neurodegeneratívnych chorôb
US5654312A (en) Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US6221915B1 (en) Pharmaceutical compositions
SK279521B6 (sk) Použitie rapamicínu
KR20160067103A (ko) 신경 장애를 치료하기 위한 토라세미드 및 바클로펜을 포함하는 조성물
KR20060123748A (ko) 통증의 치료, 변형 및 관리를 위한 면역조절 화합물을포함하는 조성물 및 이의 사용 방법
HUE035105T2 (en) A composition comprising nicotine and opipramole and its use
JP2008500374A (ja) 自己炎症性疾患の処置のためのｉｃｅインヒビター
DE60101309T2 (de) Diacerein zur behandlung von psoriasis
US6362227B1 (en) Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen
US20070054886A1 (en) Ras antagonists for treating neurodegenerative disorders
KR20050072113A (ko) 통증의 치료, 조절 및 관리를 위한 선택적 시토킨 억제약물의 사용 방법 및 이를 포함하는 조성물
WO2009139470A1 (ja) 線維筋痛症治療用医薬組成物
US4190672A (en) Method and compositions of treating Parkinsonisms with levodopa and 3',4'-dihydroxy-2-methylisopropiophenone
WO2000050019A2 (de) VERWENDUNG VON R-ARYLPROPIONSÄUREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ZUR BEHANDLUNG VON ERKRANKUNGEN BEI MENSCH UND TIER, WELCHE DURCH DIE HEMMUNG DER AKTIVIERUNG VON NF-λB THERAPEUTISCH BEEINFLUSST WERDEN KÖNNEN
JP2930281B2 (ja) 皮膚疾患処置用薬剤
ITMI952242A1 (it) Composizione farmaceutica per il trattamento delle malattie autoimmuni
JPS61176524A (ja) 抗炎症組成物
JP2024504410A (ja) 皮膚障害を治療する方法
RU2160102C2 (ru) Применение бензидамина для лечения патологических состояний, вызванных фно
JP2022503784A (ja) てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用
JPH07505128A (ja) 局所投与用薬学的組成物の調整の為の公知化合物の使用
JP2022067848A (ja) 経鼻投与用医薬組成物
Rizk et al. Comparison of the inhibitory effects of cromakalim and pinacidil (potassium channel openers) with those of oxybutynin on stimulated guinea pig and rabbit detrusor muscle strips
DE19545180A1 (de) Methode und Zusammensetzung einer topischen Therapie der Schmerzsymptomatik bei Rheuma, Arthritis und Arthrose

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090515